Najmeh Moradi et al. 2016. Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis: Economic Evaluation of Infliximab in UC Patients. Iranian Journal of Pharmaceutical Sciences. 12, 4 (Oct. 2016), 33–42. DOI:https://doi.org/10.22037/ijps.v12.40711.